A detailed history of Gries Financial LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Gries Financial LLC holds 13,704 shares of ABT stock, worth $1.54 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
13,704
Previous 14,208 3.55%
Holding current value
$1.54 Million
Previous $1.61 Million 11.83%
% of portfolio
0.33%
Previous 0.3%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$100.73 - $112.44 $50,767 - $56,669
-504 Reduced 3.55%
13,704 $1.42 Million
Q1 2024

May 15, 2024

BUY
$109.52 - $120.96 $4,709 - $5,201
43 Added 0.3%
14,208 $1.61 Million
Q4 2023

Feb 13, 2024

SELL
$90.19 - $110.4 $47,259 - $57,849
-524 Reduced 3.57%
14,165 $1.56 Million
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $47,000 - $56,393
492 Added 3.47%
14,689 $1.42 Million
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $15,822 - $17,629
157 Added 1.12%
14,197 $1.55 Million
Q1 2023

Jun 21, 2023

SELL
$96.86 - $114.01 $51,820 - $60,995
-535 Reduced 3.67%
14,040 $1.42 Million
Q4 2022

Jan 10, 2023

BUY
$95.06 - $111.52 $17,395 - $20,408
183 Added 1.27%
14,575 $1.6 Million
Q3 2022

Oct 31, 2022

SELL
$96.76 - $112.03 $5,418 - $6,273
-56 Reduced 0.39%
14,392 $1.39 Million
Q2 2022

Aug 16, 2022

BUY
$102.07 - $123.37 $2,551 - $3,084
25 Added 0.17%
14,448 $1.57 Million
Q1 2022

Apr 29, 2022

BUY
$114.02 - $139.04 $51,993 - $63,402
456 Added 3.26%
14,423 $1.71 Million
Q4 2021

Feb 02, 2022

SELL
$115.53 - $141.46 $17,560 - $21,501
-152 Reduced 1.08%
13,967 $1.97 Million
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $582,366 - $644,267
-4,992 Reduced 26.12%
14,119 $1.67 Million
Q2 2021

Aug 09, 2021

SELL
$105.79 - $124.53 $1,163 - $1,369
-11 Reduced 0.06%
19,111 $2.32 Million
Q1 2021

May 17, 2021

BUY
$108.84 - $128.23 $2.08 Million - $2.45 Million
19,122 New
19,122 $2.25 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Gries Financial LLC Portfolio

Follow Gries Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gries Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gries Financial LLC with notifications on news.